
Kellie Malloy Foerter
Chief Clinical Development Officer
OncoSec
April 1, 2020
After two decades working in the CRO industry, Kellie Malloy Foerter is applying her considerable knowledge and expertise to guide OncoSec Medical’s clinical development programs for cancers with limited treatment options. At the same time, she is tracking exciting new ways to evaluate potential new treatments in the future.